MedPath

Mycenax Biotech Inc.

Mycenax Biotech Inc. logo
🇹🇼Taiwan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:1
Completed:1

Trial Phases

2 Phases

Phase 1:2
Phase 3:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Phase 3
3 (60.0%)
Phase 1
2 (40.0%)

Phase I, Pharmacokinetic, Safety and Tolerability Study in Healthy Volunteers

Phase 1
Completed
Conditions
Pharmacokinetics
Interventions
First Posted Date
2018-05-11
Last Posted Date
2019-02-26
Lead Sponsor
Mycenax Biotech Inc.
Target Recruit Count
190
Registration Number
NCT03522012
Locations
🇦🇺

Nucleus Network, Melbourne, Victoria, Australia

A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis

Phase 3
Terminated
Conditions
Ankylosing Spondylitis
First Posted Date
2016-02-19
Last Posted Date
2019-03-12
Lead Sponsor
Mycenax Biotech Inc.
Target Recruit Count
10
Registration Number
NCT02685904
Locations
🇨🇳

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan

🇨🇳

Chung Shan Medical University Hospital, Taichung, Taiwan

🇨🇳

Far Eastern Memorial Hospital, Taipei, Taiwan

and more 3 locations

A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With DMARDs Versus DMARDs Alone in Patients With Rheumatoid Arthritis

Phase 3
Conditions
Combination With DMARDs
Interventions
First Posted Date
2013-02-08
Last Posted Date
2018-04-17
Lead Sponsor
Mycenax Biotech Inc.
Target Recruit Count
98
Registration Number
NCT01787149
Locations
🇨🇳

Cathay General Hospital, Taipei, Taiwan

🇨🇳

Cheng Hsin General Hospital, Taipei, Taiwan

🇨🇳

Far Eastern Memorial Hospital, Taipei, Taiwan

and more 4 locations

A Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With Methotrexate Versus Methotrexate Alone in Patients With RA

Phase 3
Conditions
Rheumatoid Arthritis
Interventions
First Posted Date
2012-10-18
Last Posted Date
2018-04-17
Lead Sponsor
Mycenax Biotech Inc.
Target Recruit Count
91
Registration Number
NCT01709760
Locations
🇨🇳

Changhua Christian Hospital, Changhua, Taiwan

🇨🇳

Buddhist Tzu Chi General Hospital, Chiayi City, Taiwan

🇨🇳

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan

and more 5 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.